Published online before print March 30, 2001, doi: 10.1161/hh0701.088684
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2001 American Heart Association, Inc.
Integrative Physiology |
Oxidative DNA Damage and Repair in Experimental Atherosclerosis Are Reversed by Dietary Lipid Lowering
From the Division of Pharmacology (W.M., G.R.Y.D.M., A.G.H., M.M.K.), University of Antwerp, Wilrijk, and Cardiovascular Translational Research Institute Middelheim Antwerp (M.W.M.K., M.M.K.), Antwerp, Belgium.
Correspondence to Dr Mark M. Kockx, Department of Pathology, A.Z. Middelheim, Lindendreef 1, B-2020 Antwerp, Belgium.
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Abstract—Increased oxidative stress is a major characteristic of hypercholesterolemia-induced atherosclerosis. The oxidative environment is mainly created by the production of reactive oxygen species, which are assumed to mediate vascular tissue injury. Oxidative DNA damage resulting from free radical attack remains, however, a poorly examined field in atherosclerosis. Male New Zealand White rabbits were fed a cholesterol-rich diet (0.3%) for 24 weeks. The induced atherosclerotic plaques showed elevated levels of the DNA damage marker 7,8-dihydro-8-oxoguanine (8-oxoG) as demonstrated by immunohistochemistry. 8-oxoG immunoreactivity was found predominantly in the superficial layer of the plaque containing numerous macrophage-derived foam cells but not in the media or in arteries of age-matched control animals. Alkaline single-cell gel electrophoresis revealed that the number of DNA strand breaks was significantly higher in the plaque as compared with control samples of normolipemic animals. These changes were associated with the upregulation of DNA repair enzymes (poly[ADP-ribose] polymerase-1, p53, phospho-p53 [phosphorylated at Ser392], and XRCC1 [x-ray repair cross-complementing 1]). DNA strand breaks normalized after 4 weeks of dietary lipid lowering. However, a significant reduction of 8-oxoG immunoreactivity was only observed after a prolonged period of lipid lowering (12 to 24 weeks). Repair pathways started to decline progressively when cholesterol-fed animals were placed on a normal diet. In conclusion, oxidative DNA damage and increased levels of DNA repair, both associated with diet-induced hypercholesterolemia, are strongly reduced during dietary lipid lowering. These findings may provide a better insight into the benefits of lipid-lowering therapy on plaque stabilization.
Key Words: DNA damage • DNA repair • apoptosis • oxidant stress • atherosclerosis
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Atherosclerosis is a chronic inflammatory disease of the arterial intima characterized by the formation of an atherosclerotic plaque.1 Accumulating evidence suggests that plaque formation is associated with the production of reactive oxygen species (ROS), which are currently assumed to induce oxidative tissue damage. Recent studies indicate that ROS can interact with isolated or cellular DNA to cause DNA strand breaks and/or base modifications.2 3 4 5 6 7 8 9 10 11 12 These oxidative modifications to DNA may cause mutations, preferentially at G-C base pair interactions.13 Repair of oxidative DNA damage is mediated by both base excision repair (BER) and nucleotide excision repair mechanisms.14 15 16 However, cells can respond differently to genotoxic species. Peroxynitrite-mediated DNA strand breaks, for example, may result in subsequent activation of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1).17 The physiological role of PARP-1 is still unclear, but there are indications that PARP-1 functions as a DNA repair enzyme.17 Another form of cellular response to tissue injury is the upregulation of the tumor suppressor protein p53.18 In case of moderate DNA damage, p53 mediates a transient cell cycle arrest, allowing cells to repair their DNA before entering S phase. If the extent of DNA damage is severe and perhaps beyond the capacity of repair processes, the cell may undergo necrotic or apoptotic cell death. Pronounced activation of PARP-1 (as a result of extensive DNA strand breaks) induces an energy-consuming, futile repair cycle that eventually leads to cellular energy depletion and necrotic cell death.19 Apoptosis, on the other hand, may be triggered through p53-dependent upregulation of proapoptotic factors such as BAX and PAG608.18 20 Recently, we described apoptotic cell death in atherosclerotic lesions of cholesterol-fed rabbits on the basis of in situ indices for apoptosis such as terminal deoxynucleotidyl transferase nick end labeling (TUNEL) or in situ nick translation techniques.21 Apoptosis of macrophages was mainly found in regions showing signs of DNA synthesis/repair, as demonstrated by Ki-67 and proliferating cell nuclear antigen labeling. This was in contrast with the smooth muscle cell population showing apoptosis mainly in less cellular regions that are not associated with DNA synthesis/repair. Interestingly, plaque macrophages express inducible NO synthase and seem to contain large amounts of oxidized lipids and nitrotyrosine.22 These findings support the hypothesis that macrophages are subjected to high levels of oxidative stress. Because mitotic figures are rarely found in these cells, the high levels of DNA synthesis/repair may be a response to oxidative DNA damage.
In this study, we examined the distribution of oxidative DNA damage in rabbit plaques by immunohistochemistry and single-cell gel electrophoresis. Also, the extent of DNA damage before and after dietary lipid lowering was analyzed. Furthermore, we investigated whether DNA repair systems were upregulated in response to DNA damage and whether DNA damage/repair was reversed during cholesterol withdrawal.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Cholesterol-Induced Atherosclerosis
Male New-Zealand White rabbits (28 to 3.5 kg) were fed a diet supplemented with a low-dose cholesterol (0.3%) for 24 weeks (n=54). Seventeen randomly selected animals were euthanized after this period. The other animals received a normal diet and were euthanized after a cholesterol withdrawal period of 4 weeks (n=16), 12 weeks (n=6), or 24 weeks (n=8). Seven animals remained on the cholesterol diet for 48 weeks. A control group of 15 animals receiving a cholesterol-free diet was included as well. Ten control animals were euthanized after 24 weeks, and 5 animals were euthanized after 48 weeks. An overview of the different animal groups used in this study is presented in Figure 1
. Serum was stored at -20°C, and total
cholesterol, LDL cholesterol, and
triglycerides were determined. Freshly isolated segments of
the thoracic aorta were gently pressed against an agarose-coated slide
to examine DNA strand breaks by the alkaline single-cell gel
electrophoresis assay. The segments were then fixed in 4% formalin for
histological examination. The remaining part of the
thoracic aorta was snap-frozen in liquid nitrogen for total protein
isolation. Transversal sections (5 µm thick) of paraffin-embedded
tissues were mounted on 3-aminopropyltriethoxysilane–precoated slides.
The experiments were approved by the ethical committee of the
university.
|
Antibodies
The following mouse monoclonal antibodies were used
for Western blotting and/or immunohistochemistry: anti–PARP-1 (clone
C2-10) from Pharmingen, anti–7,8-dihydro-8-oxoguanine (clone N45.1)
from the Japan Institute for the Control of Aging, anti-p53 (clone
DO-7) and anti-macrophage (RAM-11) from DAKO,
anti–phospho-p53 (S392) (clone SP2/0) from Novocastra, anti-XRCC1
(clone 33-2-5) and anti–DNA polymerase ß (clone 18S) from
Neomarkers, anti–
smooth muscle actin (clone 1A4) and
anti–ß-actin (clone AC-15) from Sigma, and anti–Ki-67 (clone MIB-1)
from Immunotech. Goat anti-mouse peroxidase–conjugated secondary
antibody was purchased from Jackson
ImmunoResearch.
Immunohistochemistry
The immunohistochemical reactions were carried out by
an indirect peroxidase antibody conjugate method as previously
described.21 At least 5
sections per animal were examined. The images were quantified by using
a color image analysis system (Soft Imaging System) as
described
elsewhere.21
Protein Isolation and Immunoblot
Assays
Rabbit aorta segments (n=4) were pooled to reduce
animal-to-animal variation and subsequently homogenized in
a buffer containing 0.9% (wt/vol) NaCl, 20 mmol/L Tris-HCl pH
7.6, 1 mmol/L phenylmethylsulfonyl fluoride, 0.01%
(wt/vol) leupeptin, and 0.2% (vol/vol) Triton X-100. Equivalent
amounts of protein (100 µg) from each animal group were loaded on a
single 10% or 12.5% SDS-polyacrylamide gel. Western blotting
of cell lysates to Hybond enhanced chemiluminescence membranes
(Amersham Pharmacia Biotech) was performed according to standard
procedures. Antibody detection was accomplished with enhanced
chemiluminescence detection reagents (Amersham Pharmacia Biotech).
Signals were visualized and quantified using a Lumi-imager (Roche
Diagnostics). After visualization of the signals, the
membranes were stripped and reprobed with a monoclonal antibody for
ß-actin.
DNA In Situ End Labeling
For the detection of oligonucleosomal DNA cleavage, a
stringent TUNEL technique was used as previously
described.23
Alkaline Single-Cell Gel Electrophoresis
Assay
The alkaline comet assay or single-cell gel
electrophoresis assay was performed according to De Boeck et
al24
(Figure 2). To determine the identity of the cells
present on the comet slides, the slides were stained with RAM-11
and -smooth muscle actin antibodies. Twenty-five randomly selected
and nonoverlapping comets were captured on disk using a
fluorescence microscope (x40 objective) coupled to a
charge-coupled device camera and image analysis system (Soft
Imaging System). Tail length (TL), tail DNA (TD; percentage of DNA in
tail), and tail moment
(TM=TLxTD)
were recorded.
|
Statistical Analysis
The results are expressed as mean±SEM. Lipid values,
the expression of DNA repair enzymes, and the comet assay
parameters between the different animal groups were
compared with 1-way ANOVA followed by the Bonferroni test. In addition,
differences in tail length and tail moment between proximal and distal
regions of the thoracic aorta were evaluated by the paired Student
t test. Plaque areas and RAM-11
immunoreactive areas were compared with a 2-way ANOVA. A value of
P<0.05 was considered
significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Serum Lipid Values
Serum lipid values at the start of the experiment, after 24 weeks of cholesterol supplementation, and after the different cholesterol withdrawal periods are shown in the Table
.
The hypercholesterolemic diet induced a pronounced
hypercholesterolemia at week 24, which was
completely reversed after 24 weeks of dietary lipid
lowering.
|
Atherosclerotic Plaques of
Cholesterol-Fed Rabbits
The induced atherosclerotic plaques showed a clear
distinction between a luminal layer composed of numerous lipid-rich
foam cells of macrophage origin and a deep layer that was
fibrous, containing extracellular lipid deposits and few smooth muscle
cells. The plaques showed signs of cell replication (Ki-67) and
apoptotic cell death (1% to 2% TUNEL-positive nuclei). After
24 weeks of dietary lipid lowering, the plaque size was unchanged.
However, the cell population was profoundly altered.
Macrophages disappeared from the plaques, whereas residing
smooth muscle cells lost their lipid content. Apoptosis was
nearly absent (<0.1% TUNEL-positive nuclei). The changes were
associated with a reduction of cell replication and increased
deposition of fibrillar collagen fibers in the plaques, which points to
plaque stabilization.
Oxidative DNA Damage in Atherosclerotic Plaques
of Cholesterol-Fed Rabbits
To investigate the extent and distribution of oxidative
DNA modifications in plaques, the DNA damage marker 8-oxoG was
demonstrated by immunohistochemistry. Arteries of
normocholesterolemic animals showed no immunoreactivity
for 8-oxoG
(Figure 3A), except for a small number of arteries in which
the endothelial cells of the adventitia and at the
luminal border were stained. In contrast, strong nuclear 8-oxoG
immunoreactivity was found in the atherosclerotic plaques of
cholesterol-fed rabbits
(Figures 3B and 3C) but not in the underlying media. 8-oxoG
immunoreactivity was present predominantly in the superficial layer
of the plaque. Although both the plaque macrophages and smooth
muscle cells were labeled, strong 8-oxoG immunoreactivity was mainly
localized in the macrophage population. Furthermore, the
endothelial cell layer and a small group of cells
present in the adventitia, mainly endothelial
cells, were positive for 8-oxoG. The majority of 8-oxoG immunoreactive
cells were not labeled by the TUNEL technique.
|
DNA strand breaks in cells derived from freshly isolated
segments of the thoracic aorta were determined by alkaline single-cell
gel electrophoresis. Comet slides contained both macrophages
and smooth muscle cells in a ratio similar to the one found in tissue
sections. The number of DNA strand breaks was significantly higher in
the plaque as compared with the samples of an age-matched control group
(Figure 4). Each cell had the appearance of a comet, with a
brightly fluorescent head and a tail with an intensity that was
related to the amount of damage sustained by the cell. There was a
significant difference in tail length between cells isolated from
segments proximal to the aortic arch and cells derived from the most
distal part of the thoracic aorta
(Figure 4). The tail moment (ie, tail lengthxpercentage DNA
in tail) in cells from proximal aorta segments was about twice as high
as compared with the distal tail moment values. The majority of cells
examined by the alkaline comet assay had a normal morphology and were
not apoptotic as demonstrated by a negative TUNEL staining.
Histological examination of the aorta segments revealed
a much more pronounced lesion formation in the upper (proximal) region
of the thoracic aorta
(Figures 5A, 5C, and 5D). The RAM-11 immunoreactive area of
the proximal lesions was not significantly different from the most
distal lesions of the thoracic aorta
(Figure 5B). The plaque area correlated with the number of
DNA strand breaks (R=0.593,
P=0.010)
(Figures 4 and 5).
|
|
DNA Repair in Atherosclerotic Plaques of
Cholesterol-Fed Rabbits
Several proteins involved in DNA repair were
upregulated in the plaque as compared with arteries of
normocholesterolemic rabbits (control animals
euthanized at 48 weeks). Western blots revealed an increased expression
of p53, p53 phosphorylated at Ser392, PARP-1, and XRCC1
(x-ray repair cross-complementing 1), but a constitutive expression of
DNA polymerase ß
(Figure 6).
|
Upregulation of DNA repair enzymes was found predominantly
in the macrophage-derived foam cells, present in the
superficial layer of the plaque
(Figure 7). However, increased immunoreactivity for PARP-1
and p53 was also found in some smooth muscle cells surrounding the
macrophage-rich area of the plaque. The smooth muscle cells in
the adjacent media did not overexpress PARP-1 or
p53.
|
DNA Damage and Repair in Atherosclerotic
Plaques of Cholesterol-Fed Rabbits After Dietary Lipid
Lowering
Dietary lipid lowering was associated with a strong
reduction of oxidative DNA damage. After a lipid-lowering period of 12
to 24 weeks, 8-oxoG immunoreactivity was significantly reduced but not
entirely abrogated
(Figures 3D
through 3F). Single-cell gel electrophoresis
showed a fast decrease in DNA strand breaks
(Figure 4). Both tail length and tail moment values
normalized after 4 weeks of cholesterol withdrawal, whereas
the differences in DNA strand breaks between the proximal and distal
parts of the thoracic aorta were no longer significant. This was in
parallel with a decline of the total plasma cholesterol and
LDL cholesterol levels
(Table).
It should be noted, however, that the plaque cell composition was
unchanged at this time point.
The expression of DNA repair enzymes, which were upregulated
during the cholesterol load, decreased progressively and
normalized after 24 weeks of cholesterol withdrawal
(Figures 6 and 7).
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Prolonged diet-induced hypercholesterolemia (0.3% cholesterol for 24 weeks) in rabbits causes intimal thickening and rapid cellular turnover, eventually culminating in the formation of an atherosclerotic lesion. We previously reported that these lesions fulfill several criteria of human atherosclerotic plaques.21 In the present study, we provide evidence that cholesterol-induced plaque formation is associated with DNA damage most likely resulting from a high degree of oxidative stress.
Mammalian cells undergo 
10 000 measurable DNA
modification events per cell per
hour.25 DNA adduct
formation, however, may increase substantially under conditions of
oxidative stress. In general, DNA damage resulting from attack by
oxygen free radicals includes base modifications, sugar damage, strand
breaks, abasic sites, and DNA
protein-cross-links.13
8-oxoG is one of the most abundant lesions in DNA generated by
oxidative stress.26 Using
monoclonal antibody N45.1, which is highly specific for
8-oxoG,27 28 29
elevated levels of 8-oxoG were found in the superficial layer of the
plaque containing numerous macrophage-derived foam cells
but not in the underlying media. Moreover, alkaline single-cell gel
assays demonstrated that the number of DNA strand breaks raised
significantly in the plaque as compared with samples of normolipemic
animals. Cells containing a large number of DNA strand breaks were
found predominantly in segments close to the aortic arch that showed
pronounced atherosclerotic lesions. This suggests a relationship
between the number of DNA strand breaks and plaque size. Theoretically,
the alkaline single-cell gel assay allows detection of both
single-strand and double-strand DNA breaks. Double-strand breaks are
generally considered to be of greater biological consequence than
single-strand DNA breaks, because they can lead directly to chromosome
aberrations and loss of genetic material. However, it has been reported
that ROS induce solely nicks into
DNA,3 4 5
so we may assume that the DNA breaks detected in the plaque are mainly
single-stranded.
Although cells possess many defense systems that prevent formation of DNA damage, the BER pathway is believed to be the primary defense against oxidative damage.14 15 16 BER involves several proteins that act to excise a damaged nucleobase from DNA and replace it with the correct undamaged nucleotide. 8-oxoG lesions are typically removed by BER. In contrast, DNA strand breaks are sensed by several kinases such as the DNA-dependent protein kinase30 or the ataxia-telangiectasia mutated gene product ATM31 leading to phosphorylation and activation of p53. Recently, it has been postulated that this phenomenon plays a principal part in the progression of atherosclerosis, because absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo.32 After 24 weeks of cholesterol supplement, plaques showed a strong upregulation of p53. The protein was detectable predominantly in the macrophage population of the plaque and was absent in the adjacent media as well as in the aorta of age-matched normocholesterolemic rabbits. At present, multiple p53 posttranslational modifications are known that may stabilize the protein.18 We found that p53 became phosphorylated in the plaque on Ser392, but we cannot exclude other modifications taking place as well.
It is well established that oxidative DNA damage can induce apoptosis through activation of p53. Active p53 transmits the apoptotic signal by a complicated mechanism that involves, at least in part, its ability to transactivate target genes such as BAX and a series of p53-inducible genes.33 Although many smooth muscle cells in the plaque express Bax,21 apoptotic nuclei as visualized by the TUNEL technique were scarce and did not correlate with the number of 8-oxoG immunoreactive cells. Indeed, the TUNEL technique detects oligonucleosomal DNA breaks but is probably not sensitive enough to identify low numbers of DNA breaks. This indicates that cells in the plaque may contain 8-oxoG modifications and a small number of DNA breaks (detectable by the comet assay) without undergoing the execution phase of apoptosis.
In addition to p53, PARP-1 was stimulated to participate in DNA repair. PARP-1 binds both double- and single-stranded DNA breaks in a non–sequence-dependent manner and catalyzes the addition of long branched chains of poly(ADP-ribose) to a variety of nuclear proteins, most notably PARP-1 itself.17 According to recent studies, PARP-1 interacts directly with the BER protein XRCC134 and appears to play an important role in p53 activation and regulation after DNA damage.17 XRCC1 in turn interacts with the BER proteins DNA ligase III35 and DNA polymerase ß.36 Consequently, it was concluded that PARP-1 could detect nicks in DNA and then recruits other members of the BER pathway to the site of DNA damage. Because atherosclerotic plaques showed elevated levels of both PARP-1 and XRCC1, these processes may play a relevant role in atherosclerosis to preserve the genome. However, in case of massive DNA damage, PARP-1 activation leads to cellular energy depletion and necrosis.19 In this regard, DNA repair may also contribute to necrotic core formation, the hallmark of an advanced unstable lesion.
Recent studies have shown that the discontinuation of a cholesterol-rich diet in rabbits has beneficial effects on the architecture of the lesions.21 37 After a prolonged cholesterol withdrawal period, morphological changes include increases in smooth muscle cells and collagen, as well as reductions in macrophage number, extracellular lipid, and calcifications. Moreover, smooth muscle cells lose their lipid accumulation and show reduced expression of the proapoptotic factor Bax.21 38 Together with a less frequently observed rate of apoptosis and a drastic increase of cross-banded collagen fibers, these changes point to an increased tensile strength of the plaque. In addition to these morphological benefits, we demonstrate here that the lesions are cleared of oxidative DNA damage, indicating presence of an efficient DNA repair mechanism. Because oxidative damage to DNA can exert a number of deleterious effects, including mutations and induction of apoptosis,13 efficient removal of DNA adducts may contribute to stabilization of the plaque. Interestingly, repair of DNA strand breaks as detected by the alkaline comet assay proceeded much faster than repair of 8-oxoG lesions, so we can assume that decreased levels of DNA strand breaks reflect an early event in plaque stabilization. This is consistent with earlier reports showing that repair of endogenous damage highly depends on the type of DNA lesion. Apurinic/apyrimidinic sites, for example, are removed over relatively short times, whereas repair of oxidized bases (especially purine lesions such as 8-oxoG) is a rather slow process.16
Taken together, our data fit into the following model. During hypercholesterolemia-induced atherogenesis, ROS are formed resulting in oxidative DNA damage. DNA damage is followed by increased DNA repair activity so that initial damage is efficiently repaired and, more importantly, remains sublethal. However, some cells may reach a point of no return, after which the DNA repair systems can no longer cope with the extensive damage and apoptotic cell death becomes imminent. During cholesterol withdrawal, most macrophages disappear from the plaque. A reduction of both ROS formation and oxidative tissue injury can be observed as well. Subsequently, DNA repair systems normalize and the vessel wall starts to recover. More work is certainly required to understand the potential role of oxidatively damaged DNA in the pathogenesis of atherosclerosis. Nevertheless, we believe that this model may help to explain the benefits of lipid-lowering therapy on plaque stabilization.
|
Acknowledgments |
|---|
This research was supported by the Bekales Foundation and by the Fund for Scientific Research-Flanders (Projects 1.5.206.00 and G.0080.98). M.M.K. is holder of a fund for fundamental clinical research from the Fund for Scientific Research–Flanders. We are indebted to Martine De Bie for excellent technical assistance.
|
Footnotes |
|---|
Original received October 6, 2000; revision received February 5, 2001; accepted February 13, 2001.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233–241.
2. Henle ES, Linn S. Formation, prevention and repair of DNA damage by iron/hydrogen peroxide. J Biol Chem. 1997;272:19095–19098.
3. Inoue S, Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett. 1995;371:86–88.
4. Salgo MG, Stone K, Squadrito GL, Battista JR, Pryor WA. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem Biophys Res Commun. 1995;210:1025–1030.
5. Szabo C, Zingarelli B, O’Connor M, Salzman AL. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A. 1996;93:1753–1758.
6. Yermilov V, Rubio J, Becchi M, Friesen MD, Pignateli B, Ohshima H. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis. 1995;16:2045–2050.
7. Yermilov V, Rubio J, Ohshima H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 1995;376:207–210.
8. Douki T, Cadet J. Peroxynitrite mediated oxidation of purine bases of nucleosides and isolated DNA. Free Radic Res. 1996;24:369–380.
9. Epe B, Ballmaier D, Roussyn I, Briviba K, Sies H. DNA damage by peroxynitrite characterized with DNA repair enzymes. Nucleic Acids Res. 1996;24:4105–4110.
10. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A. 1992;89:3030–3034.
11. DeRojas-Walker T, Tamir S, Ji H, Wishnok JS, Tannenbaum SR. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol. 1995;8:473–477.
12. Caulfield JL, Wishnok JS, Tannenbaum SR. Nitric oxide-induced deamination of cytosine and guanine in deoxynucleosides and oligonucleotides. J Biol Chem. 1998;273:12689–12695.
13. Wang D, Kreutzer DA, Essigmann JM. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat Res. 1998;400:99–115.
14. Croteau DL, Bohr VA. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997;272:25409–25412.
15. Lindahl T, Wood RD. Quality control by DNA repair. Science. 1999;286:1897–1905.
16. Frosina G. Overexpression of enzymes that repair endogenous damage to DNA. Eur J Biochem. 2000;267:2135–2149.
17. Pieper AA, Verma A, Zhang J, Snyder SH. Poly(ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci. 1999;20:171–181.
18. Bennett MR. Mechanisms of p53-induced apoptosis. Biochem Pharmacol. 1999;58:1089–1095.
19. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A. 1999;96:13978–13982.
20. Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerm A, Oren M. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J. 1997;16:4384–4392.
21. Kockx MM, De Meyer GRY, Buyssens N, Knaapen MWM, Bult H, Herman AG. Cell composition, replication and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res. 1998;83:378–387.
22. Cromheeke KM, Kockx MM, De Meyer GRY, Bosmans JM, Bult H, Beelaerts WJF, Vrints CJ, Herman AG. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Res. 1999;43:744–754.
23. Kockx MM, Muhring J, Knaapen MWM, de Meyer GRY. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol. 1998;152:885–888.
24. De Boeck M, Lison D, Kirsch-Volders M. Evaluation of the in vitro direct and indirect genotoxic effects of cobalt compounds using the alkaline comet assay: influence of interdonor and interexperimental variability. Carcinogenesis. 1998;19:2021–2029.
25. Moustacchi E. DNA damage and repair: consequences on dose-responses. Mutat Res. 2000;464:35–40.
26. Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem. 1997;272:19633–19636.
27. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest. 1997;76:365–374.
28. Toyokuni S, Iwasa Y, Kondo S, Tanaka T, Ochi H, Hiai H. Intranuclear distribution of 8-hydroxy-2'-deoxyguanosine: an immunocytochemical study. J Histochem Cytochem. 1999;47:833–835.
29. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int. 1999;49:91–102.
30. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PWK. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature. 1998;394:700–704.
31. Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 1998;281:1674–1679.
32. Guevara NV, Kim H-S, Antonova EI, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 1999;5:335–339.
33. Polyak K, Xia Y, Zweier JL, Kinzier KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389:300–305.
34. Masson M, Niedergang C, Schreiber V, Muller S, Ménissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18:3563–3571.
35. Nash RA, Caldecott KW, Barnes DE, Lindahl T. XRCC1 protein interacts with one of two distinct forms of DNA ligase III. Biochemistry. 1997;36:5207–5211.
36. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase ß and the XRCC1 protein. EMBO J. 1996;15:6662–6670.
37. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff Sukhova GK, Libby P. Lipid lowering by diet reduces matrix metalloproteinase and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998;97:2433–2444.
38. Seye CI, De Meyer GRY, Knaapen MWM, Bult H, Herman AG, Kockx MM. Apoptosis and formation of Bax homodimers in atherosclerosis are reversed by dietary lipid lowering. Circulation. 1999;100(suppl I):I-774. Abstract.
This article has been cited by other articles:
 |
|
 |
|
  M. Mahmoudi, I. Gorenne, J. Mercer, N. Figg, T. Littlewood, and M. Bennett Statins Use a Novel Nijmegen Breakage Syndrome-1-Dependent Pathway to Accelerate DNA Repair in Vascular Smooth Muscle Cells Circ. Res., September 26, 2008; 103(7): 717 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Folkmann, S. Loft, and P. Moller Oxidatively damaged DNA in aging dyslipidemic ApoE-/- and wild-type mice Mutagenesis, March 1, 2007; 22(2): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Gorenne, M. Kavurma, S. Scott, and M. Bennett Vascular smooth muscle cell senescence in atherosclerosis Cardiovasc Res, October 1, 2006; 72(1): 9 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mahmoudi, J. Mercer, and M. Bennett DNA damage and repair in atherosclerosis Cardiovasc Res, July 15, 2006; 71(2): 259 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Zschenker, T. Illies, and D. Ameis Overexpression of lysosomal Acid lipase and other proteins in atherosclerosis. J. Biochem., July 1, 2006; 140(1): 23 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hesse, H. Siedler, S. P. Luntz, B. M. Arendt, R. Goerlich, R. Fricker, M. Heer, and W. E. Haefeli Modulation of endothelial and smooth muscle function by bed rest and hypoenergetic, low-fat nutrition J Appl Physiol, December 1, 2005; 99(6): 2196 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, J. Yang, and L. K. Jennings Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H659 - H666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Mulvihill, J. Jaeger, R. Sengupta, W. L. Ruzzo, C. Reimer, S. Lukito, and S. M. Schwartz Atherosclerotic Plaque Smooth Muscle Cells Have a Distinct Phenotype Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1283 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. COOKE, M. D. EVANS, M. DIZDAROGLU, and J. LUNEC Oxidative DNA damage: mechanisms, mutation, and disease FASEB J, July 1, 2003; 17(10): 1195 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Martinet, M. W.M. Knaapen, G. R.Y. De Meyer, A. G. Herman, and M. M. Kockx Overexpression of the Anti-Apoptotic Caspase-2 Short Isoform in Macrophage-Derived Foam Cells of Human Atherosclerotic Plaques Am. J. Pathol., March 1, 2003; 162(3): 731 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Martinet, D. M. Schrijvers, G. R.Y. De Meyer, J. Thielemans, M. W.M. Knaapen, A. G. Herman, and M. M. Kockx Gene Expression Profiling of Apoptosis-Related Genes in Human Atherosclerosis: Upregulation of Death-Associated Protein Kinase Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2023 - 2029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Xu Role of Heat Shock Proteins in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1547 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bartunek, M. Vanderheyden, M. W. M. Knaapen, W. Tack, M. M. Kockx, and M. Goethals Deoxyribonucleic acid damage/repairproteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1097 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. PALINSKI and C. NAPOLI The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis FASEB J, September 1, 2002; 16(11): 1348 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Martinet, M. W.M. Knaapen, G. R.Y. De Meyer, A. G. Herman, and M. M. Kockx Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques Circulation, August 20, 2002; 106(8): 927 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Durand, Z. Mallat, F. Addad, F. Vilde, M. Desnos, C. Guerot, A. Tedgui, and A. Lafont Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1680 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Bennett Reactive Oxygen Species and Death : Oxidative DNA Damage in Atherosclerosis Circ. Res., April 13, 2001; 88(7): 648 - 650. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||